Related references
Note: Only part of the references are listed.Briakinumab for Treatment of Crohn's Disease: Results of a Randomized Trial
Remo Panaccione et al.
INFLAMMATORY BOWEL DISEASES (2015)
IL23R polymorphisms influence phenotype and response to therapy in patients with ulcerative colitis
Marilia L. Cravo et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2014)
Susceptibility to ulcerative colitis in Hungarian patients determined by gene-gene interactions
Patricia Sarlos et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Difference of interleukin-23 receptor gene haplotype variants in ulcerative colitis compared to Crohn's disease and psoriasis
Eniko Safrany et al.
INFLAMMATION RESEARCH (2013)
Marked diversity of IL23R gene haplotype variants in rheumatoid arthritis comparing with Crohn's disease and ankylosing spondylitis
Melinda Szabo et al.
MOLECULAR BIOLOGY REPORTS (2013)
Associations between interleukin-23R polymorphisms and ankylosing spondylitis susceptibility: a meta-analysis
Young Ho Lee et al.
INFLAMMATION RESEARCH (2012)
Association of IL23R polymorphisms with psoriasis and psoriatic arthritis: a meta-analysis
Kun-Ju Zhu et al.
INFLAMMATION RESEARCH (2012)
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis
Axel Dignass et al.
JOURNAL OF CROHNS & COLITIS (2012)
Associations between interleukin-23 receptor polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis
Gwan Gyu Song et al.
MOLECULAR BIOLOGY REPORTS (2012)
Association of interleukin 23 receptor gene polymorphisms (rs10489629, rs7517847) with rheumatoid arthritis in European population: a meta-analysis
Yu Zhai et al.
MOLECULAR BIOLOGY REPORTS (2012)
Association of Single Nucleotide Polymorphisms of IL23R and IL17 with Ulcerative Colitis Risk in a Chinese Han Population
Pengli Yu et al.
PLOS ONE (2012)
IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease
Alessandra Geremia et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Disease Activity, ANCA, and IL23R Genotype Status Determine Early Response to Infliximab in Patients With Ulcerative Colitis
Matthias Juergens et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Genome-wide association identifies multiple ulcerative colitis susceptibility loci
Dermot P. B. McGovern et al.
NATURE GENETICS (2010)
Cutting Edge: IL-23 Receptor GFP Reporter Mice Reveal Distinct Populations of IL-17-Producing Cells
Amit Awasthi et al.
JOURNAL OF IMMUNOLOGY (2009)
Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study
Mark S. Silverberg et al.
NATURE GENETICS (2009)
Signal transduction and Th17 cell differentiation
John J. O'Shea et al.
MICROBES AND INFECTION (2009)
Interleukin (IL)-23 receptor is a major susceptibility gene for Graves' ophthalmopathy: The IL-23/T-helper 17 axis extends to thyroid autoimmunity
Amanda K. Huber et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Susceptibility genetic variants in Hungarian morbus Crohn and ulcerative colitis patients
Lili Magyari et al.
ORVOSI HETILAP (2008)
rs1004819 Is the Main Disease-Associated IL23R Variant in German Crohn's Disease Patients: Combined Analysis of IL23R, CARD15, and OCTN1/2 Variants
Juergen Glas et al.
PLOS ONE (2007)
A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis
Gerald G. Krueger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
After interleukin-12p4O, are interleukin-23 and interleukin-17 the next therapeutic targets for inflammatory bowel disease?
Zili Zhang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2007)
A genome-wide association study identifies IL23R as an inflammatory bowel disease gene
Richard H. Duerr et al.
SCIENCE (2006)
Anti-interleukin-12 antibody for active Crohn's disease
PJ Mannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)